Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Resilient Biotics, a US-based developer of microbiome-based treatments for respiratory infections in animals, has raised $7.1m in a series A round co-led by Berkeley Catalyst Fund, a venture unit aligned to University of California (UC) Berkeley, according to AgFunderNews. Fulcrum Global Capital co-led the round, which also included veterinary medicine producer Elanco Animal Health as well as Innovation in Motion and Viking Global Investors.
B Dot Medical, a Japan-based proton beam therapy developer, had raised a total of ¥700m…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
